Literature DB >> 17285617

Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura?

Christine M Cserti1, Stephen Landaw, Lynne Uhl.   

Abstract

Several case reports have suggested an association between infections and thrombotic thrombocytopenic purpura (TTP). In Case 1, a 37-year-old female presented with TTP 6 times over 7 years, requiring 242 therapeutic plasma exchanges (TPE), for a per-course range of 4-57 TPE (median 48), and treatment durations of 4-241 days (median 71 days), largely on account of multiple exacerbations (range 0-3, median 3). Twelve of 17 (71%) of her presentations or exacerbations were associated with suspected infections, with confirmation in 9 episodes. These included pulmonary TB, CMV pneumonitis, mucocutaneous HSV, ventilator-associated or urinary tract-associated gram-negative sepsis, central line-associated staphylococcal bacteremia, and cellulitis. Except for TB, all infections occurred after splenectomy, which had been performed on day 33 of presentation 1. In Case 2, a 24-year-old female presented with TTP 3 times over 15 months. Her courses were managed with brief courses of TPE (5-11 treatments per course, median 5). Suppressed ADAMTS13 levels due to inhibitors were confirmed twice. Presentation 1 was antedated by atypical community acquired pneumonia. Presentation 3 (and possibly 2) followed prolonged, progressive, antibiotic-refractory periodontal infections ultimately requiring exodontic surgery. Our cases add to a literature that suggests that infection may be associated with exacerbations or relapses of TTP in some patients. Our patients demonstrated repeated TTP exacerbations in association with different infectious agents. A better understanding of the possible relationship between infection and clinical expression of TTP might lead to improved treatment decisions for patients with this complex illness. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17285617     DOI: 10.1002/jca.20114

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  10 in total

Review 1.  Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange.

Authors:  Claudia Rizzo; Sergio Rizzo; Elisabetta Scirè; Danilo Di Bona; Carlo Ingrassia; Giovanni Franco; Roberto Bono; Gerlando Quintini; Calogero Caruso
Journal:  Blood Transfus       Date:  2012-06-27       Impact factor: 3.443

2.  Systemic infections mimicking thrombotic thrombocytopenic purpura.

Authors:  Kristina K Booth; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Am J Hematol       Date:  2011-09       Impact factor: 10.047

3.  Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura.

Authors:  X Long Zheng; Sara K Vesely; Spero R Cataland; Paul Coppo; Brian Geldziler; Alfonso Iorio; Masanori Matsumoto; Reem A Mustafa; Menaka Pai; Gail Rock; Lene Russell; Rawan Tarawneh; Julie Valdes; Flora Peyvandi
Journal:  J Thromb Haemost       Date:  2020-09-11       Impact factor: 5.824

4.  Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy: first report from iran.

Authors:  Mohammadreza Ardalan; Parisa Rezaeifar
Journal:  Nephrourol Mon       Date:  2014-11-11

5.  Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome.

Authors:  Chakradhar Venkata; Rahul Kashyap; J Christopher Farmer; Bekele Afessa
Journal:  J Intensive Care       Date:  2013-12-30

Review 6.  The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.

Authors:  Felice Gragnano; Simona Sperlongano; Enrica Golia; Francesco Natale; Renatomaria Bianchi; Mario Crisci; Fabio Fimiani; Ivana Pariggiano; Vincenzo Diana; Andreina Carbone; Arturo Cesaro; Claudia Concilio; Giuseppe Limongelli; Mariagiovanna Russo; Paolo Calabrò
Journal:  Mediators Inflamm       Date:  2017-05-28       Impact factor: 4.711

7.  Cytomegalovirus induced refractory TTP in an immunocompetent individual: a case report.

Authors:  Medhini Boteju; Praveen Weeratunga; Ahalyaa Sivashangar; Thashi Chang
Journal:  BMC Infect Dis       Date:  2019-05-08       Impact factor: 3.090

Review 8.  Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura.

Authors:  Aicha Laghmouchi; Nuno A G Graça; Jan Voorberg
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

Review 9.  VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP.

Authors:  Michael Schwameis; Christian Schörgenhofer; Alice Assinger; Margarete M Steiner; Bernd Jilma
Journal:  Thromb Haemost       Date:  2014-12-11       Impact factor: 5.249

10.  Acute Hepatitis Caused by Genotype 4 HCV Presenting with Microangiopathic Hemolytic Anemia.

Authors:  Ahmed Kamal; Ayman Hafez Youssef; Amal Refaat Mansour
Journal:  ACG Case Rep J       Date:  2018-10-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.